一个疑似由palonosetron和ramosetron管理引起的血清激素综合征病例
1Department of Anesthesiology and Pain Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea.
Journal of exercise rehabilitation
|November 6, 2023
概括
血清激素综合征是一种罕见的疾病,可能是由血清激素 (5-基三胺,5-HT) 水平的增加引起的,通常与5-HT3抗剂的过量服用有关. 早期识别临床症状对于患者管理至关重要.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 血清激素综合征是一种潜在的危及生命的疾病,其特点是精神状态的改变,神经肌肉异常和自主性过度活动.
- 血清素受体3 (5-HT3) 抗剂因其抗emetic 特性而广泛使用,特别是在全身麻醉期间.
- 过量服用5-HT3抗剂可能会提高血清中的血清激素水平,增加血清激素毒性的风险.
研究的目的:
- 阐明与血清激素综合征相关的机制和风险,特别是与5-HT3抗剂有关的风险.
- 突出临床识别和治疗血清素综合征的重要性,因为它的稀有性和潜在的严重性.
主要方法:
- 关于血清素综合征和5-HT3抗剂的药理学现有文献的综述.
- 分析潜在的促成因素,包括药物相互作用和高剂量管理.
- 强调临床表现作为主要的诊断和管理指南.
主要成果:
- 血清素综合征是由于血清素 (5-基三胺,5-HT) 活性过高而产生的.
- 过度使用或与其他血清激素药物结合时,5-HT3抗剂可以导致这种综合征.
- 由于这种疾病的罕见性和从临床试验中被排除在外,血清激素综合征的确切发病率尚不清楚.
结论:
- 医生必须依靠临床表现来诊断和管理血清素综合征.
- 及时识别和干预对于预防严重或致命的结果至关重要.
- 了解像5-HT3抗剂这样的药物的血清激素作用对于患者的安全至关重要.
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
216
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
216
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
270
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
270
01:23Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
305
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
305
01:17Drugs for Treatment of Diarrhea-Predominant IBS
186
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
186
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
410
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
410